These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4109834)

  • 21. Bioavailability of digoxin tablets and elixir in the fasting and postprandial states.
    Greenblatt DJ; Duhme DW; Koch-Weser J; Smith TW
    Clin Pharmacol Ther; 1974 Sep; 16(3):444-8. PubMed ID: 4412196
    [No Abstract]   [Full Text] [Related]  

  • 22. Biologic availability of digoxin tablets.
    Skelly JP; Knapp G
    JAMA; 1973 Apr; 224(2):243. PubMed ID: 4739497
    [No Abstract]   [Full Text] [Related]  

  • 23. Letter: Discrepancy between solution and bioavailability of digoxin tablets.
    Banes D
    Lancet; 1975 Mar; 1(7907):629. PubMed ID: 47966
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of area under the curve to estimate absolute bioavailability of digoxin.
    Kramer WG; Reuning RH
    J Pharm Sci; 1978 Jan; 67(1):141-2. PubMed ID: 619109
    [No Abstract]   [Full Text] [Related]  

  • 25. Letter: Discrepancy between solution and bioavailability of digoxin tablets.
    Ylitalo P; Wilén G; Lundell S
    Lancet; 1975 Feb; 1(7902):343. PubMed ID: 46493
    [No Abstract]   [Full Text] [Related]  

  • 26. Biological availability of digoxin.
    Shaw TR
    Br Heart J; 1973 May; 35(5):554-5. PubMed ID: 4577277
    [No Abstract]   [Full Text] [Related]  

  • 27. [Biopharmaceutical characteristics of digoxin tablets].
    Avico U; Signoretti Ciranni E; Zuccaro P; Cingolani E; Foschi F; Paciaroni E
    Boll Chim Farm; 1976 Jun; 115(6):432-9. PubMed ID: 1008948
    [No Abstract]   [Full Text] [Related]  

  • 28. [Improved bioavailability of Israeli digoxin tablets with increased dissolution rates].
    Halkin H; Farfel Z; Saginer P; Millman P; Gibbor Y
    Harefuah; 1977 Oct; 93(7-8):189-91. PubMed ID: 924245
    [No Abstract]   [Full Text] [Related]  

  • 29. Therapeutic non-equivalence of digoxin tablets in the United Kingdom: correlation with tablet dissolution rate.
    Shaw TR; Raymond K; Howard MR; Hamer J
    Br Med J; 1973 Dec; 4(5895):763-6. PubMed ID: 4758573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical study on digoxin tablets with high bioavailability (author's transl)].
    Flasch CI; Heinz N
    Arzneimittelforschung; 1979; 29(6):961-4. PubMed ID: 582792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discrepancy between solution and bioavailability of digoxin tablets.
    Ylitalo P; Wilén G; Lundell S
    Lancet; 1975 Mar; 1(7909):744. PubMed ID: 47503
    [No Abstract]   [Full Text] [Related]  

  • 32. Variation in biologic availability of digoxin from four preparations.
    Lindenbaum J; Mellow MH; Blackstone MO; Butler VP
    N Engl J Med; 1971 Dec; 285(24):1344-7. PubMed ID: 5121186
    [No Abstract]   [Full Text] [Related]  

  • 33. Variation in the biological availability of digoxin.
    Shaw TR; Howard MR; Hamer J
    Lancet; 1972 Aug; 2(7772):303-7. PubMed ID: 4115034
    [No Abstract]   [Full Text] [Related]  

  • 34. [Biological availability of digoxin and beta-acetyldigoxin after single-dose administration (author's transl)].
    Clasen R; Kemmeter H; Gilfrich HJ
    Dtsch Med Wochenschr; 1979 Apr; 104(15):543-6. PubMed ID: 436626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unchanged absorption of digoxin tablets in patients with cardiac failure.
    Meister W; Benowitz NL; Benet LZ
    Pharmacology; 1984; 28(2):90-4. PubMed ID: 6709691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of high-dose cancer chemotherapy on the absorption of digoxin in two different formulations.
    Bjornsson TD; Huang AT; Roth P; Jacob DS; Christenson R
    Clin Pharmacol Ther; 1986 Jan; 39(1):25-8. PubMed ID: 3943266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single dose bioavailability of two different digoxin tablets.
    Jonkman JH; Gusdorf CF; van der Boon WJ; Grasmeijer G; Jedema JN
    Arzneimittelforschung; 1987 Jan; 37(1):62-5. PubMed ID: 3566859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Digoxin absorption from tablets and elixir. The effect of radiation-induced malabsorption.
    Jusko WJ; Conti DR; Molson A; Kuritzky P; Giller J; Schultz R
    JAMA; 1974 Dec; 230(11):1554-5. PubMed ID: 4479663
    [No Abstract]   [Full Text] [Related]  

  • 39. Bioavailability of digoxin from tablets. II. Radioimmunoassay and disposition pharmacokinetics of digoxin after intravenous administration.
    Nyberg L; Andersson KE; Bertler A
    Acta Pharm Suec; 1974 Nov; 11(5):459-70. PubMed ID: 4440504
    [No Abstract]   [Full Text] [Related]  

  • 40. Bioavailability of drugs: the digoxin dilemma.
    Greenblatt DJ; Smith TW; Koch-Weser J
    Clin Pharmacokinet; 1976; 1(1):36-51. PubMed ID: 797491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.